Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer

NCT03150706 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Avelumab

Sponsor

Asan Medical Center

Collaborators

[object Object]